MAP2K7 and glioblastoma: We also validated the FAK+MEK inhibitor combination using the human GBM G7 cell line, which has previously been shown to maintain markers of GBM stem cells and display a growth pattern in CD1 nude mice xenografts characteristic of high-grade gliomas in patients [51] (Figure 8).